Wegovy is a brand name for semaglutide 2.4 mg, a medication used for chronic weight management in adults with obesity or overweight who have at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol. It is a higher dose formulation of semaglutide compared to the formulation used for diabetes treatment.

Like Ozempic, Wegovy belongs to the class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists. Semaglutide 2.4 mg works by mimicking the action of the hormone GLP-1, which helps regulate appetite, reduce food intake, and promote weight loss.

Celebrities such as Sharon Osbourne and Stephen Fry popularised the use of the weight loss management drug.